Secondary Hyperparathyroidism, Chronic Kidney Disease
3 clinical trials · Condition
◉ Watch Secondary Hyperparathyroidism, Chronic Kidney Disease
| Record | Firm | Date |
|---|---|---|
| Study of MT1013 for the Treatment of Patients With Secondary Hyperparathyroidism (NCT07122401) | Shaanxi Micot Pharmaceutical Technology Co., Ltd. | 2025-09-30 |
| Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis (NCT02859896) | Sanofi | 2017-01-19 |
| Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis (NCT02341417) | Amgen | 2015-06-10 |
Track Secondary Hyperparathyroidism, Chronic Kidney Disease automatically
Every clearance here is in the API, with alerts when new ones post.